Novo Nordisk A/S

NYSE: NVO · Real-Time Price · USD
52.32
1.37 (2.69%)
At close: Aug 15, 2025, 3:02 PM

Novo Nordisk A/S Cash Flow Statement

Financials in DKK. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
100.99B 83.68B 55.52B 47.76B
Depreciation & Amortization
8.54B 9.41B 7.36B 6.03B
Stock-Based Compensation
2.29B 2.15B 1.54B 1.04B
Other Working Capital
8.11B -631M 2.63B 2.19B
Other Non-Cash Items
-5.06B 4.92B 6.26B -2.49B
Deferred Income Tax
26.2B 20.99B 13.54B 11.32B
Change in Working Capital
-11.99B -12.24B -5.34B -8.66B
Operating Cash Flow
120.97B 108.91B 78.89B 55B
Capital Expenditures
-51.31B -38.9B -14.75B -7.38B
Cash Acquisitions
-82.16B n/a -7.08B -18.28B
Purchase of Investments
-19.81B -13.29B -9.73B -7.11B
Sales Maturities Of Investments
24.39B 8.29B 6.64B 1.17B
Other Investing Acitivies
-4.14B -13.09B -5.7B 4M
Investing Cash Flow
-128.9B -43.89B -24.92B -31.61B
Debt Repayment
73.06B -1.47B -2.41B 15.47B
Common Stock Repurchased
-20.18B -29.92B -24.09B -19.45B
Dividend Paid
-44.14B -31.77B -25.3B -21.52B
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
8.73B -63.16B -51.8B -25.49B
Net Cash Flow
1.26B 1.74B 1.93B -1.51B
Free Cash Flow
69.66B 70.01B 64.13B 47.62B